Amid rising cases of Human Metapneumovirus (HMPV) in India, former AIIMS Director Dr. Randeep Guleria has urged people not to panic. Known for his pivotal role during the COVID-19 pandemic, Dr. Guleria emphasized that HMPV is a manageable respiratory illness requiring primarily symptomatic treatment.
Key Facts About HMPV
HMPV is not a new virus; it was first identified in 2001 and has been a common cause of acute respiratory infections. While it typically leads to mild symptoms, it can cause severe complications like pneumonia in vulnerable groups, including infants, young children, the elderly, and those with preexisting health conditions.
Symptoms and Treatment
HMPV symptoms often include:
•Cough
•Runny or congested nose
•Fever
•Fatigue
In severe cases, symptoms may escalate to wheezing, shortness of breath, or pneumonia, especially in high-risk individuals.
Dr. Guleria stressed that the virus is usually self-limiting and does not require antibiotics. Treatment involves managing symptoms:
•Stay hydrated
•Take paracetamol for fever and body aches
•Use anti-allergic medication for cough and cold if needed
“There’s no specific antiviral drug for HMPV, and antibiotics are ineffective since it’s a viral infection,” he explained.
Prevention Tips
Preventing HMPV involves simple hygiene measures:
•Wash hands frequently with soap
•Avoid close contact with sick individuals
•Disinfect commonly touched surfaces regularly
•Cover coughs and sneezes
•Stay home if feeling unwell
Since HMPV spreads through respiratory droplets, direct contact, and contaminated surfaces, these precautions are crucial, especially during its peak seasons in late winter and spring.
Vulnerable Groups
Infants under five and older adults are at greater risk of severe illness due to weaker immune systems. Symptoms typically appear 3-6 days after exposure and may last 1-2 weeks.
Dr. Guleria concluded by advising people to avoid crowded places to curb the spread of the virus and focus on maintaining good nutrition and hydration.